NRXP Institutional Ownership & Shareholders

NRX PHARMACEUTICALS INC (NRXP) is currently held by 46 institutional investors tracked by InsiderSet, with a combined reported market value of approximately $47.44M based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026.

B Group, Inc. is currently the largest disclosed institutional shareholder of NRXP tracked by InsiderSet, reporting ownership valued at approximately $16.74M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $8.88M, representing an estimated loss of -46.94% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 88% of the total disclosed NRXP value among the investors covered in this analysis. Major shareholders include B Group, Inc., Vanguard Capital Management Llc, Ameriprise Financial Inc, and several other long-term asset managers with concentrated positions in NRX PHARMACEUTICALS INC (NRXP).

This page ranks the largest institutional NRXP shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

46

Total Reported Value

$47.44M

Largest Holder

B Group, Inc.

Largest Position

$16.74M

Insider Transactions (90d)

0

Latest Filing Quarter

Q2 2026

New Institutional Positions

56

Funds Exiting Positions

0

NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
B Group, Inc.9.50%4,091,767$16,735,327$8,879,134-$7,856,193-46.94%
Vanguard Capital Management Llc0.00%1,618,159$6,618,270$3,511,405-$3,106,865-46.94%
Ameriprise Financial Inc0.00%928,728$3,798,498$2,015,340-$1,783,158-46.94%
Balyasny Asset Management L.P.0.01%893,864$3,655,904$1,939,685-$1,716,219-46.94%
Citadel Advisors Llc0.00%680,043$2,781,376$1,475,693-$1,305,683-46.94%
Advisorshares Investments Llc0.33%659,018$2,695,384$1,430,069-$1,265,315-46.94%
Ubs Group Ag0.00%423,115$1,730,540$918,160-$812,380-46.94%
Commonwealth Equity Services, Llc0.00%590,768$1,725,040$1,281,967-$443,073-25.68%
Geode Capital Management, Llc0.00%314,659$1,287,102$682,810-$604,292-46.95%
Blackrock, Inc.0.00%220,460$901,681$478,398-$423,283-46.94%
Marshall Wace, Llp0.00%194,580$795,831$422,239-$373,592-46.94%
Vanguard Fiduciary Trust Co0.00%182,718$747,317$396,498-$350,819-46.94%
Jane Street Group, Llc0.00%119,018$486,784$258,269-$228,515-46.94%
Bleakley Financial Group, Llc0.01%117,216$479,413$254,359-$225,054-46.94%
State Street Corp0.00%116,084$474,784$251,902-$222,882-46.94%
Hrt Financial Lp0.00%100,724$411,000$218,571-$192,429-46.82%
Prime Capital Investment Advisors, Llc0.00%124,631$363,923$270,449-$93,474-25.69%
Northern Trust Corp0.00%62,951$257,470$136,604-$120,866-46.94%
Quadrature Capital Ltd0.00%43,605$178,344$94,623-$83,721-46.94%
Morgan Stanley0.00%40,901$167,285$88,755-$78,530-46.94%
Renaissance Technologies LLCJim Simons0.00%38,600$157,874$83,762-$74,112-46.94%
Chicago Partners Investment Group Llc0.00%47,542$118,380$103,166-$15,214-12.85%
Two Sigma Investments, Lp0.00%26,429$108,095$57,351-$50,744-46.94%
Exoduspoint Capital Management, Lp0.00%19,308$78,970$41,898-$37,072-46.94%
Xtx Topco Ltd0.00%18,545$75,849$40,243-$35,606-46.94%
Virtu Financial Llc0.00%16,614$68,000$36,052-$31,948-46.98%
Persistent Asset Partners Ltd0.02%16,326$66,773$35,427-$31,346-46.94%
Cresset Asset Management, Llc0.00%15,000$61,350$32,550-$28,800-46.94%
Sbi Securities Co., Ltd.0.00%20,001$58,403$43,402-$15,001-25.69%
Truist Financial Corp0.00%20,000$58,400$43,400-$15,000-25.68%
Squarepoint Ops Llc0.00%13,166$53,849$28,570-$25,279-46.94%
Ethos Financial Group, Llc0.00%15,900$51,357$34,503-$16,854-32.82%
Millennium Management Llc0.00%12,305$50,327$26,702-$23,625-46.94%
Sjbenen Advisory, Llc0.03%15,000$41,978$32,550-$9,428-22.46%
Citigroup Inc0.00%5,992$24,507$13,003-$11,504-46.94%
Vanguard Global Advisers, Llc0.00%5,773$23,612$12,527-$11,085-46.94%
Tower Research Capital Llc (Trc)0.00%3,884$15,886$8,428-$7,458-46.95%
Security National Bank0.00%4,200$12,264$9,114-$3,150-25.68%
Wells Fargo & Company/Mn0.00%2,000$8,180$4,340-$3,840-46.94%
Royal Bank Of Canada0.00%2,000$8,000$4,340-$3,660-45.75%
Barclays Plc0.00%900$3,681$1,953-$1,728-46.94%
Osaic Holdings, Inc.0.00%600$2,454$1,302-$1,152-46.94%
Avion Wealth0.00%294$1,000$638-$362-36.20%
Jpmorgan Chase & Co0.00%34$136$74-$62-45.75%
Larson Financial Group Llc0.00%22$90$48-$42-46.96%
Steward Partners Investment Advisory, Llc0.00%1$4$2-$2-45.75%
Showing 46 of 46

Frequently asked questions about NRXP

  • Who are the largest institutional holders of NRXP?

    The largest institutional holders of NRXP reported in the latest SEC Form 13F filings include B Group, Inc., Vanguard Capital Management Llc, Ameriprise Financial Inc, Balyasny Asset Management L.P., and Citadel Advisors Llc. InsiderSet ranks institutional holders by their latest reported NRXP position.

  • What is NRXP institutional ownership?

    This page tracks NRXP positions reported by institutional investment managers through SEC Form 13F. NRX PHARMACEUTICALS INC (NRXP) institutional ownership on InsiderSet reflects disclosed 13F holdings among the managers we analyze, not every shareholder of the stock.

  • How many institutions own NRXP?

    InsiderSet currently tracks 46 institutional managers reporting NRXP holdings in the latest available 13F data. This count reflects institutions included in the SEC Form 13F filings analyzed by InsiderSet and should not be interpreted as the total number of NRXP shareholders.

  • How much NRXP stock do institutions own?

    Institutional investment managers disclosed approximately $47.44M in NRXP holdings for Q2 2026. This figure is reported 13F value as of the filing period, not necessarily today's market value.

  • When was NRXP institutional ownership last updated?

    The latest NRXP institutional ownership data on InsiderSet is based on SEC Form 13F filings for the quarter ended June 30, 2026. Form 13F filings are generally reported after the quarter ends, so the holdings shown represent the latest publicly disclosed positions rather than real-time institutional holdings.

  • Are institutional NRXP holdings real-time?

    No. Form 13F data is not real-time. It represents positions reported by institutional investment managers as of the end of the reporting quarter. An institution may have changed its NRXP position after the reporting date.

  • Are institutions buying or selling NRXP?

    Institutional buying and selling can be analyzed by comparing NRXP positions across consecutive 13F reporting periods. InsiderSet's NRXP Ownership Changes page shows institutions that increased, reduced, initiated, or exited positions based on reported 13F holdings. View NRXP ownership changes.

  • How has NRXP institutional ownership changed over time?

    InsiderSet tracks NRXP institutional holdings across multiple 13F reporting periods, allowing investors to compare institutional holder counts, reported value, and reported shares over time.